James Slover, MD
Orthopedic Surgery · New York, NYNPI 1851355564
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,828 of the $12,746 with a category attached, or 77.1%. Amgen accounts for 88.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $11,744 and has fallen 99.7% since, to $36 in 2025.
Across 31 payments — averaging $411.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$11K
- Zimmer Biomet$582
- Medtronic$273
- Smith+Nephew$210
- Medical Device Business Services, Inc.$147
- Stryker$124
- plus $177 from 2 others
Across 9 payments — averaging $641.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$6K
What the payments were for
- Speaking & faculty fees$9,82877%
- Travel & lodging$1,0488%
- Food & beverage$1,86915%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $11,231 |
| Zimmer Biomet | 8 | $582 |
| Medtronic | 3 | $273 |
| Smith+Nephew | 2 | $210 |
| Medical Device Business Services, Inc. | 1 | $147 |
| Stryker | 5 | $124 |
| Restor3d, Inc. | 1 | $102 |
| KCI USA, Inc. | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUEXIS$959
- AQUAMANTYS$258
- T-Fix$170
- Journey II BCS$170
- PICO 7 Single Use Negative Pressure Wound Therapy$170
- REDAPT Revision Hip System$170
- ATTUNE$147
- Persona$132
How this compares
$12,746 in reported general payments places this provider in the 85th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 37 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in New York
- Baron LonnerNew York$2.1M
- Lon WeinerNew York$622K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Stephen ObrienNew York$17K
- Tyler LucasNew York$7K
- Afshin RaziNew York$3K
- Benjamin RosenstadtNew York$2K
- Peter FrelinghuysenNew York$266
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.